General Information
Revision date
2017-08-03
Product name
Ondansetron Injection 4 mg/2 mL and 8 mg/4 mL
Manufacturer Name
Accord Healthcare Pty Ltd
Icons in SDS
Company Information
company name
Accord Healthcare Pty Ltd
Section 2
SECTION 2: Hazards identification
Appearance: A clear colorless solution filled in clear glass ampoule. Physical State: Liquid
Principle Routes of Exposure
The material is intended for intravenous or intramuscular use Fire and Explosion Expected to be non-combustible. Health Caution - Potent pharmaceutical agent. Health effects information is based on hazards of components. Handling this product in its final form presents minimal risk from occupational exposure. Possible effects of overexposure in the workplace include: symptoms of hypersensitivity (such as skin rash, hives, itching, and difficulty breathing); headache; constipation; flushing; abnormal nervous system sensations.
Environmental hazards
No information is available about the potential of this product to produce adverse